Ticker
CRNXCompany Name
CRINETICS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -301.8M | -21681.03% | $ 1.39M |
3/31/2025 | $ -261.57M | -34416.58% | $ 760K |
12/31/2024 | $ -225.97M | -21748.8% | $ 1.04M |
9/30/2024 | $ -199.81M | -19231.09% | $ 1.04M |
6/30/2024 | $ -178.33M | -12875.6% | $ 1.39M |
3/31/2024 | $ -178.44M | -9039.77% | $ 1.97M |
12/31/2023 | $ -166.31M | -4144.21% | $ 4.01M |
9/30/2023 | $ -163M | -3451.91% | $ 4.72M |
6/30/2023 | $ -160.14M | -3312.76% | $ 4.83M |
3/31/2023 | $ -142.38M | -3322.75% | $ 4.29M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for CRINETICS PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -59.54M ] / Revenues [ $ 392K ]
(=) OCF % [ -15187.76% ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |